West Pharmaceutical Services, Inc. (WST)WSTWest Pharmaceutical Services, Inc.

SEC Filings

Filing links are provided when reliable SEC filing data is available.

Recent Filings

Form	Filing Date	Accepted	Document
SC 13G	Aug 6, 2026	Aug 6, 2026	View filing
10-Q	Jul 23, 2026	Jul 23, 2026	View filing
8-K	Jul 23, 2026	Jul 23, 2026	View filing
8-K	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 1, 2026	Jul 1, 2026	View filing
8-K	Jun 1, 2026	Jun 1, 2026	View filing
8-K/A	May 20, 2026	May 20, 2026	View filing
4	May 14, 2026	May 14, 2026	View filing
SD	May 13, 2026	May 13, 2026	View filing
8-K	May 11, 2026	May 11, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
4	May 6, 2026	May 6, 2026	View filing
8-K	May 5, 2026	May 5, 2026	View filing
SC 13G	Apr 30, 2026	Apr 30, 2026	View filing
SC 13G	Apr 29, 2026	Apr 29, 2026	View filing
4	Apr 29, 2026	Apr 29, 2026	View filing
4	Apr 29, 2026	Apr 29, 2026	View filing
10-Q	Apr 23, 2026	Apr 23, 2026	View filing
8-K	Apr 23, 2026	Apr 23, 2026	View filing
4	Apr 1, 2026	Apr 1, 2026	View filing
SC 13G/A	Mar 27, 2026	Mar 27, 2026	View filing
DEFA14A	Mar 12, 2026	Mar 12, 2026	View filing

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA

10,800 employees

www.westpharma.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Eric Green

View full financials